An inspiring story of resilience and determination is unfolding in Lakeshore, Ontario, as a mother of two, Ashley Bigelow, plans a run to raise funds for ovarian cancer research. After battling and overcoming ovarian cancer, Bigelow, a paramedic with Essex-Windsor EMS, is now on a mission to give back and support others facing similar challenges.
At the age of 31, Bigelow received a shocking ovarian cancer diagnosis following a surgery to remove an ovarian cyst. Despite the initial darkness and uncertainty that came with the diagnosis, Bigelow persevered through multiple surgeries, including a total hysterectomy, and numerous follow-up appointments. Recently receiving the all-clear from her doctors, Bigelow is now preparing to return to her normal life.
Having experienced the fear and anxiety that often accompanies a cancer diagnosis, Bigelow is determined to shine a light on the importance of ovarian cancer research. She has organized a satellite Run for Ovarian Cancer in Lakeshore, with the goal of raising funds for cancer research through the London Health Sciences Foundation.
Team Biggs, formed by Bigelow, will participate in the run on Mother’s Day, with the support of friends and family, including her two children. The event is set to become an annual tradition, with Bigelow hoping to inspire others with her recovery journey and dedication to supporting ovarian cancer research.
With a fundraising goal of $5,000, Bigelow has launched a public campaign to encourage donations towards this important cause. By sharing her story and organizing the run, Bigelow aims to raise awareness about ovarian cancer and contribute to the ongoing efforts to improve screening methods and treatment options for the disease.
Joining Team Biggs at the Atlas Tube Centre in Lakeshore on Mother’s Day, supporters will have the opportunity to participate in a meaningful event that celebrates resilience, community support, and the power of giving back. Together, they will run to make a difference and help change the lives of those affected by ovarian cancer.